Business
AstraZeneca COVID-19 vaccine faces regulatory hurdles as Novavax releases both ‘encouraging’ and ‘concerning’ results – ABC News
European regulatory bodies are questioning the lack of data supplied for the Oxford-AstraZeneca vaccine, recommending against its use for the elderly, as another…
Experts say the problems associated with “first-generation” COVID-19 vaccines are being exposed, as one European regulatory body questions the lack of data supplied for the Oxford-AstraZeneca vaccine and recommends against its use for the elderly.
Key points:
- European regulatory bodies are concerned over the lack of data for the elderly during trials of the Oxford-AstraZeneca vaccine
- The TGA, described as “the best regulator in the world” by the Health Minister, is expected to make a decision in…
Continue Reading
-
Business22 hours ago1 Australian stock you’ll probably kick yourself for not owning a decade from now
-
General17 hours agoLiberals go back to basics after crawling to year’s end
-
Business23 hours ago3 of the best ASX ETFs to build significant wealth
-
General20 hours agoWho’s thriving and who’s barely surviving in Australia, the Land of the Parrots?